We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+12.36%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$525M
AUM Growth
+$163M
Cap. Flow
-$365M
Cap. Flow %
-69.47%
Top 10 Hldgs %
34.54%
Holding
251
New
–
Increased
–
Reduced
–
Closed
140

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
SAGE
Sage Therapeutics
SAGE
+$17.3M
2
GIS icon
General Mills
GIS
+$16.1M
3
HGV icon
Hilton Grand Vacations
HGV
+$13.9M
4
D icon
Dominion Energy
D
+$13.5M
5
ACGL icon
Arch Capital
ACGL
+$12.4M

Sector Composition

Rank Sector Weight
1 Healthcare 20.2%
2 Financials 16.74%
3 Technology 15.78%
4 Industrials 10.99%
5 Energy 7.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SBT
51
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
– –
0
– –
TSC
52
DELISTED
TriState Capital Holdings, Inc.
TSC
– –
0
– –
TECX
53
Tectonic Therapeutic
TECX
$606M
– –
0
– –
ZYME icon
54
Zymeworks
ZYME
$1.67B
– –
0
– –
LMNR icon
55
Limoneira
LMNR
$251M
– –
0
– –
XERS icon
56
Xeris Biopharma Holdings
XERS
$1.45B
– –
0
– –
FSCT
57
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
– –
-150,000
Closed -$4.87M
BAND
58
Bandwidth Inc
BAND
$1.61B
– –
0
– –
OPTN
59
DELISTED
OptiNose
OPTN
– –
0
– –
NESRW
60
DELISTED
National Energy Services Reunited Corp. Warrant
NESRW
– –
-1,595,557
Closed -$1.85M
INBK icon
61
First Internet Bancorp
INBK
$255M
– –
0
– –
IMGN
62
DELISTED
Immunogen Inc
IMGN
– –
0
– –
EIDX
63
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
– –
0
– –
EVER icon
64
EverQuote
EVER
$906M
– –
0
– –
TSLX icon
65
Sixth Street Specialty
TSLX
$1.81B
– –
-190,000
Closed -$3.48M
MLNT
66
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
– –
0
– –
CDTX
67
DELISTED
Cidara Therapeutics
CDTX
– –
0
– –
KDMN
68
DELISTED
Kadmon Holdings, Inc.
KDMN
– –
0
– –
EPAY
69
DELISTED
Bottomline Technologies Inc
EPAY
– –
-60,000
Closed -$2.68M
ESQ icon
70
Esquire Financial Holdings
ESQ
$1.14B
– –
-75,600
Closed -$1.9M
VRCA icon
71
Verrica Pharmaceuticals
VRCA
$87.3M
– –
0
– –
UNVR
72
DELISTED
Univar Solutions Inc.
UNVR
– –
-252,080
Closed -$6.96M
CASA
73
DELISTED
Casa Systems, Inc. Common Stock
CASA
– –
0
– –
BOX icon
74
Box
BOX
$4.6B
– –
-70,000
Closed -$1.74M
GPP
75
DELISTED
Green Plains Partners LP
GPP
– –
-106,046
Closed -$1.83M
1 2
3
4 5

Similar funds

SWMG
Sard Wealth Management Group Atlanta, Georgia $184M AUM 11.26% 1-Year Est. Return
IFPL
Investments & Financial Planning LLC Lexington, Kentucky $184M AUM 17.7% 1-Year Est. Return
RFG
RFP Financial Group Atlanta, Georgia $184M AUM 16.06% 1-Year Est. Return
NAM
Nutshell Asset Management Sevenoaks, United Kingdom $184M AUM 2.02% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return
GCA
GSI Capital Advisors Newport Beach, California $184M AUM 5.17% 1-Year Est. Return
IVGAV
Index Venture Growth Associates V St. Helier, Jersey $184M AUM

Monashee Investment Management's Q2 2018 Portfolio in Review

As of Q2 2018, Monashee Investment Management held 251 positions worth $525M, up 45% from $362M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Monashee Investment Management withdrew a net $365M in Q2 2018, closing 140 positions. Its most notable exit was Sage Therapeutics, an estimated $17.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Financials and Technology.

  • Monashee Investment Management fully exited Sage Therapeutics in Q2 2018, selling an estimated $17.3M.
  • Monashee Investment Management's ten largest holdings make up 35% of its $525M portfolio in Q2 2018.
  • Monashee Investment Management opened 0 new positions and closed 140 in Q2 2018.
  • Monashee Investment Management's portfolio value rose 45% quarter-over-quarter to $525M.

Based on Monashee Investment Management's 13F filing for Q2 2018, filed 10 Aug 2018.